ARI

ARI is an externally-managed commercial real-estate mortgage REIT in the late innings of a CRE credit downcycle, and the filing tells that story plainly. The MD&A devotes its critical-accounting discussion to CECL allowances, loan-specific (Specific CECL) reserves for borrowers 'experiencing financial difficulty,' and to 'real estate owned' — collateral taken via foreclosure or deed-in-lieu on defaulted loans. That is the mechanical explanation for the earnings whipsaw: net income swung from +$265M (FY2022) to +$58M (FY2023) to -$120M (FY2024) and back to +$127M (FY2025, +205.9%). The FY2025 'recovery' is largely a normalization off heavy prior-year credit provisions, not organic growth — revenue actually fell 10.6% to $272M and is down from the $345M FY2023 peak as the loan book shrinks and problem assets are resolved.

The balance sheet shows a portfolio being managed down under stress, not expanding healthily. Operating cash flow dropped 28.8% to $143M, cash fell 55.9% to $140M, and the accumulated deficit deepened to -$850M. Most telling, dividends paid were cut 24% to $141M — at ~140M shares that is roughly $1.00/share, still above the $0.81 GAAP EPS, meaning the distribution leans on distributable (CECL-excluded) earnings and the prior cut was a defensive move. ROE is a thin 6.8% and liabilities run 4.33x equity (total liabilities $8.04B vs. $1.86B equity), normal leverage for a mortgage REIT but it amplifies any further credit marks in office/CRE collateral.